In Vitro Induction of Neuromuscular Junctions from Engineered Human-Induced Pluripotent Stem Cells

Published: September 27, 2024

Abstract

Source:Lin, C. et al., In vitro Neuromuscular Junction Induced from Human Induced Pluripotent Stem Cells. J. Vis. Exp.(2020).

This experiment details a method for generating neuromuscular junctions from human-induced pluripotent stem cells. It uses a staged differentiation process to promote myotube and motor neuron development and synapse formation, yielding functional neuromuscular junctions.

Protocol

1. Preparation of extracellular matrix (ECM)-coated plates

  1. Dilute ECM (see Table of Materials) with ice cold 1x PBS to a final concentration of 2%
  2. Add 1 mL of ECM to 49 mL of 1x PBS in a 50 mL plastic tube. Mix well by pipetting up and down several times.
  3. Place 1 coverslip into each well of a 6-well plate. Add 1.5 mL of 2% ECM into each well.
  4. Incubate the well plate with 2% ECM for 2 h at 37 °C.
  5. Aspirate ECM from the well plate and store the plate at 4 °C before use.

2. Differentiation of iPSCs toward NMJ

  1. Seed 4 x 105 of iPSCs per well on the 6-well plate prepared in section 1. Make sure to seed the cells on the coverslip pre-deposited in the well.
    NOTE: In this study, the 201B7MYOD iPS cell line was used.
    1. Remove the medium from the iPSCs on the 6 cm culture dish and wash the iPSCs once with 1x PBS.
    2. Add 1 mL of cell detachment solution to the dish and incubate for 10 min at 37 °C.
    3. Add 3 mL of primate embryonic stem (ES) cell medium to the dish and gently pipette 3 times.
    4. Collect the supernatant, which contains detached iPSCs, into a 50 mL plastic tube and centrifuge at 160 x g at 4 °C for 5 min.
    5. Carefully aspirate the supernatant, resuspend the iPSCs in 3 mL primate ES cell medium with 10 µM Y27632, and count the cell number using a hemocytometer.
    6. Dilute the iPSCs with primate ES cell medium and 10 µM Y27632 to a concentration of 2 x 105 cells/mL. Add 2 mL of iPSCs on the coverslip pre-deposited in the well described in section 1.

3. Induction of the iPSCs to NMJ

  1. On day 1, 24 h after seeding the iPSCs to the 6-well plate, remove the culture medium and replace it with 2 mL of fresh primate ES cell medium containing 1 µg/mL doxycycline to each well.
  2. Change the medium with 2 mL of myogenic differentiation medium (MDM) (Table 1) containing 1 µg/mL doxycycline (final concentration) to each well. Refresh the medium every day from day 2 to day 10.
  3. From day 11, switch the medium to 2 mL of NMJ medium (Table 1) to each well. Refresh the medium every 3‒4 days thereafter until day 30.
  4. Observe the differentiated NMJ by phase inverted microscopy on day 30. The NMJ can be used for the following analysis.

Representative Results

Table 1: Formula of medium.

Myogenic differentiation medium (MDM) MEM-alpha 500mL
100mM 2-ME 1117μL
Doxycycline 1μg/mL
KSR 56mL (final to 10%)
Pen/Strep 2.5mL
total 560mL
100mM 2-mercaptoethanol 2-mercaptoethanol 7μL
d.d. water 993μL
total 1000μL
NMJ medium Neurobasal medium (NB) 500mL
B27 1x (stock in 50x)
BDNF 10ng/mL
GDNF 10ng/mL
N2 1x (stock in 100x)
NT3 10ng/mL
Pen/Strep 2.5mL

Açıklamalar

The authors have nothing to disclose.

Materials

Medium, growth factors and reagents
2-mercaptoethanol Nacalai tesque 21418-42
B27, Gibco Gibco 12587-001
BDNF R & D Systems 248-BD
Cell detachment solution, Accumax STEMCELL Technologies #07921
Critical point dryer Hitachi ES-2030
Doxycycline Takara 631311
ECM, Matrigel (growth factor reduced) Corning 356230
GDNF R & D Systems 212-GD
Gelation, IP gel Geno Staff PG20-1
Ions coater JEOL JEC3000FC
iPSC medium, mTeSR STEMCELL Technologies 85850
KnockOut SR (KSR) Gibco 10828-028
live cell microscopy Nikon Eclipse Ti microscope
MEM-alpha Gibco 12571-071
N2, Gibco Gibco 17502-048
Neurobasal medium Gibco 21103-049
NT3 R & D Systems 267-N3
Primate ES cell medium ReproCell RCHEMD001
SEM Hitachi S-4700
TEM Hitachi H7650
Y27632 Wako Chemicals GmbH 253-00513

Play Video

Bu Makaleden Alıntı Yapın
In Vitro Induction of Neuromuscular Junctions from Engineered Human-Induced Pluripotent Stem Cells. J. Vis. Exp. (Pending Publication), e22582, doi: (2024).

View Video